peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma pa tients after hepatectomy/ablation
2Xiufeng Liu,Feng Xia,Yue Chen,Huichuan Sun,Zhengqiang Yang,Bo Chen,Ming Zhao,Xinyu Bi,Tao Peng,Aizier Ainiwaer,Zhiwen Luo,Fusheng Wang,Yinying Lu,National Clinical Research Center for Infectious Diseases,Society of Hepatology,Beijing Medical Association,Translational Medicine Branch,China Association of Gerontology and Geriatrics.Chinese expert consensus on refined diagnosis,treatment,and management of advanced primary liver cancer(2023 edition)[J].Liver Research,2024,8(2):61-71.
